Request Your Free White Paper Now:

"The Role of Local Laboratories in HIV and HCV Diagnosis and Prevention"

This white paper from Hologic describes the molecular testing capabilities community laboratories have taken on to test locally for HIV and HCV during the COVID-19 pandemic and the benefits that local testing brings, including more rapid results, proximity to care, and the dissemination of expertise.

Though the COVID-19 pandemic caused setbacks in infectious disease surveillance, testing, and care, it did stimulate advancements and upgrades to laboratories’ automated platforms. Many community laboratories that previously sent their HIV and HCV viral load testing out to reference labs today have the technology, expertise, and desire to offer virology testing in-house. When combined with consolidated menus and automated, off-hours operation, these laboratories can meet rising demand without higher costs or reduction in quality, maximizing recently adopted platforms to bring essential VL assays closer to patients.

Offered Free by: Hologic
See All Resources from: Hologic